Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results

-- Cash runway extended into Q2 2024 --

Related Keywords

Canada ,Australia ,United States ,Canadian ,Dane Andreeff ,Lisam Wilson ,Healthtech Connex ,Ministry Of Health ,Patient Therapy Access Program ,Exchange Commission ,School Of Rehabilitation ,Nasdaq ,Site Communications Inc ,Company Po ,Helius Medical Technologies Inc ,Pons Therapeutic Experience Program Po ,Wolters Kluwer Health ,Company Annual Report On Form ,Medical Technologies ,Recent Business ,Portable Neuromodulation Stimulator ,Durable Medical Equipment ,Social Services ,Experience Program ,Pacific Blue Cross ,Chief Executive Officer ,Canadian Healthcare ,Helius Medical Technologies ,Portable Neuromodulation ,Securities Litigation Reform Act ,Key Opinion Leaders ,Annual Report ,United States Securities ,In Site Communications ,Condensed Consolidated Statements ,Region ,